Literature DB >> 12723721

Bone metastasis as the first manifestation of lung cancer.

K Kagohashi1, H Satoh, H Ishikawa, M Ohtsuka, K Sekizawa.   

Abstract

Bone metastasis usually occurs late in the course of the disease, but in some patients it is the first manifestation of lung cancer. To evaluate the characteristics of patients with bone metastasis as a first manifestation of lung cancer, the medical records of 1063 patients with lung cancer between 1976 and 2001 were reviewed retrospectively. Twenty-four (2.3%) lung cancer patients presented symptoms of bone metastasis as a first manifestation; 11 patients had bone metastasis as the only site of spread in lung cancer; 16 had adenocarcinoma; five had a primary lesion <30 mm, and nine had N0-1 disease. Patients with sole bone metastasis did not have a more favourable survival rate than patients with bone and other systemic metastases (p=0.2938). Whether metastasis is the first manifestation of lung cancer or not, the occurrence of bone metastasis generally means a poor prognosis.

Entities:  

Mesh:

Year:  2003        PMID: 12723721

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  11 in total

1.  Surprise met in minor ops.

Authors:  Stephen Mulgrew; Richard Newton; Anna Khoo; David Camp
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

2.  Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.

Authors:  Ying Fan; Yue Dong; Huan Wang; Hongbo Wang; Xinyan Sun; Xiaoyu Wang; Peng Zhao; Yahong Luo; Xiran Jiang
Journal:  Eur Radiol       Date:  2022-06-22       Impact factor: 7.034

3.  99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer.

Authors:  Esther Mena; Valle Camacho; Montserrat Estorch; Jordi Fuertes; Albert Flotats; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

4.  Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR.

Authors:  Jinsong Li; Huayun Deng; Meichun Hu; Yuanzhang Fang; Amanda Vaughn; Xiaopan Cai; Leqin Xu; Wei Wan; Zhenxi Li; Shijie Chen; Xinghai Yang; Song Wu; Jianru Xiao
Journal:  Oncotarget       Date:  2015-03-30

5.  Incidence and consequences of bone metastases in lung cancer patients.

Authors:  Michael Kuchuk; Christina L Addison; Mark Clemons; Iryna Kuchuk; Paul Wheatley-Price
Journal:  J Bone Oncol       Date:  2013-01-17       Impact factor: 4.072

Review 6.  AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions.

Authors:  Judith A Paice; Matt Mulvey; Michael Bennett; Patrick M Dougherty; John T Farrar; Patrick W Mantyh; Christine Miaskowski; Brian Schmidt; Thomas J Smith
Journal:  J Pain       Date:  2016-11-21       Impact factor: 5.820

7.  Pattern of bone metastasis in patients with nonsmall cell lung cancer.

Authors:  Kunihiko Miyazaki; Toshihiro Shiozawa; Hideyasu Yamada; Tomohiro Tamura; Hiroaki Satoh
Journal:  Ann Thorac Med       Date:  2018 Oct-Dec       Impact factor: 2.219

8.  Detection of rib metastases in patients with lung cancer: a comparative study of MRI, CT and bone scintigraphy.

Authors:  Yan-Qing Chen; Yang Yang; Yan-Fen Xing; Sen Jiang; Xi-Wen Sun
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

9.  Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?

Authors:  Mélanie Deberne; Stanislas Ropert; Bertrand Billemont; Catherine Daniel; Jeanne Chapron; François Goldwasser
Journal:  BMC Cancer       Date:  2014-06-10       Impact factor: 4.430

10.  Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.

Authors:  Soo Bin Park; Jung Mi Park; Seung Hwan Moon; Young Seok Cho; Jong-Mu Sun; Byung-Tae Kim; Kyung-Han Lee
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.